Teva Inks Texas Opioids Settlement And Eyes J&J’s Nationwide ‘Formula’

Israeli Giant Spells Out ~$3bn Nationwide Settlement Ambition; Wants Deal In 2022

3D rendering conceptual image of dollars, symbolizing the rising prices - Illustration
Teva wants existing shareholders to benefit once legal issues are settled • Source: Shutterstock: elsar

More from Legal & IP

More from Generics Bulletin